Status:
UNKNOWN
Outcomes of Elective Cancer Surgery During the COVID-19 Pandemic Crisis
Lead Sponsor:
University of Birmingham
Conditions:
COVID-19
Coronavirus
Eligibility:
All Genders
18+ years
Brief Summary
CovidSurg-Cancer is an international, multicentre, observational cohort study designed to evaluate the 30-day COVID-19 infection rates in elective cancer surgery during the COVID-19 pandemic. Centres...
Detailed Description
The rapid emergence of the COVID-19 virus has led to a global impact on elective surgical care. We have very little evidence to guide us. The magnitude and effects of these changes are uncertain. The...
Eligibility Criteria
Inclusion
- Centre
- \- Any centre performing elective cancer surgery
- Inclusion Criteria (patient):
- Adults (age ≥18 years) with a confirmed diagnosis of an included cancer type
- Decision made for surgical management with a curative intent
Exclusion
- Surgery planned with non-curative intent
- Planned neoadjuvant therapy without a firm date for surgery, or awaiting restaging
Key Trial Info
Start Date :
March 30 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2020
Estimated Enrollment :
1000 Patients enrolled
Trial Details
Trial ID
NCT04384926
Start Date
March 30 2020
End Date
December 31 2020
Last Update
May 12 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital del Henares
Madrid, Spain